Axogen Inc vs iShares MBS ETF — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while iShares MBS ETF trades at $92.85. The key difference: Axogen Inc is trading nearer its 52-week high, iShares MBS ETF nearer its low. Which is the better fit depends on your goals.
| AXGN | MBB | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | — |
52-Week High | $48.48 | $96.91 |
52-Week Low | $14.16 | $92.72 |
Enterprise Value | $2.52B | — |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →The fund will invest at least 80% of its assets in the component securities of the underlying index and TBAs that have economic characteristics that are substantially identical to the economic characteristics of the component securities of the index, and the fund will invest at least 90% of its assets in fixed income securities included in the underlying index that advisor believes will help the fund track the index.
Read more on MBB →